---
title: "Noveome Biotherapeutics, Inc. SEC filings"
url: https://altstreet.investments/edgar/1478304
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Noveome Biotherapeutics, Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | Noveome Biotherapeutics, Inc. |
| CIK | 1478304 |
| Filing family | Form D |
| Total offering amount (as filed) | $15,000,000 |
| Total sold (as reported) | $6,750,503 |
| Investors (as reported) | 6 |

## Filings (8 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| August 27, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830426000003/ |
| August 8, 2024 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830424000001/ |
| August 17, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830423000001/ |
| October 2, 2020 | D | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830420000001/ |
| April 22, 2019 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830419000001/ |
| January 24, 2018 | D | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830418000004/ |
| April 14, 2016 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830416000005/ |
| January 13, 2016 | D | Form D | https://www.sec.gov/Archives/edgar/data/1478304/000147830416000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1478304
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001478304&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1478304
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
